
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/05/2025 | Q3 | $229.5M | -- | -- | $1.47 | -- |
06/04/2025 | Q2 | $193.8M | $193.7M | $1.60 | $1.09 | $0.51 |
03/27/2025 | Q1 | $197.5M | $232.5M | $2.22 | $1.15 | $1.08 |
12/05/2024 | Q4 | $225.6M | $257M | $2.00 | $1.26 | $0.74 |
09/05/2024 | Q3 | $191.1M | $227M | $1.31 | $0.97 | $0.34 |
06/06/2024 | Q2 | $134.8M | $157.7M | $0.58 | $0.52 | $0.06 |
04/11/2024 | Q1 | $162.1M | $164.6M | $0.89 | $0.75 | $0.14 |
12/06/2023 | Q4 | -- | -- | $0.40 | $0.86 | -$0.46 |
09/06/2023 | Q3 | -- | -- | $0.94 | $0.75 | $0.20 |
06/08/2023 | Q2 | -- | -- | $0.16 | $0.37 | -$0.21 |
04/12/2023 | Q1 | -- | -- | $1.00 | $0.71 | $0.29 |
12/07/2022 | Q4 | -- | -- | $0.56 | $0.74 | -$0.18 |
09/08/2022 | Q3 | -- | -- | $0.30 | $0.39 | -$0.09 |
06/08/2022 | Q2 | -- | -- | $0.50 | $0.33 | $0.17 |
04/13/2022 | Q1 | -- | -- | $0.14 | $0.26 | -$0.12 |
12/08/2021 | Q4 | -- | -- | $0.78 | $0.52 | $0.27 |
09/07/2021 | Q3 | -- | -- | $0.81 | $0.48 | $0.33 |
06/08/2021 | Q2 | -- | -- | $0.67 | $0.35 | $0.33 |
04/14/2021 | Q1 | -- | -- | $0.60 | $0.47 | $0.13 |
12/09/2020 | Q4 | -- | -- | $0.60 | $0.32 | $0.29 |
09/09/2020 | Q3 | -- | -- | $0.36 | $0.05 | $0.31 |
06/09/2020 | Q2 | -- | -- | -$0.05 | -$0.08 | $0.03 |
04/14/2020 | Q1 | -- | -- | -$0.46 | -$0.07 | -$0.40 |
12/10/2019 | Q4 | -- | -- | -$0.44 | -$0.13 | -$0.31 |
09/09/2019 | Q3 | -- | -- | $0.07 | $0.03 | $0.05 |
06/10/2019 | Q2 | -- | -- | -$1.78 | -$0.12 | -$1.66 |
04/10/2019 | Q1 | -- | -- | -$0.05 | -$0.12 | $0.07 |
12/06/2018 | Q4 | -- | -- | $2.07 | $0.34 | $1.74 |
09/05/2018 | Q3 | -- | -- | $1.08 | $0.40 | $0.68 |
06/11/2018 | Q2 | -- | -- | $0.31 | $0.34 | -$0.03 |
04/11/2018 | Q1 | -- | -- | $0.47 | $0.73 | -$0.26 |
12/06/2017 | Q4 | -- | -- | $1.09 | $0.99 | $0.10 |
09/07/2017 | Q3 | -- | -- | $1.72 | $1.03 | $0.69 |
06/07/2017 | Q2 | -- | -- | $1.31 | $0.93 | $0.39 |
04/10/2017 | Q1 | -- | -- | $1.29 | $0.81 | $0.48 |
12/06/2016 | Q4 | -- | -- | $1.16 | $0.75 | $0.41 |
09/06/2016 | Q3 | -- | -- | $1.29 | $0.69 | $0.60 |
06/07/2016 | Q2 | -- | -- | $0.81 | $0.88 | -$0.07 |
04/14/2016 | Q1 | -- | -- | $0.45 | $0.65 | -$0.20 |
12/10/2015 | Q4 | -- | -- | $0.72 | $0.67 | $0.05 |
09/08/2015 | Q3 | -- | -- | $0.75 | -- | -- |
Argan reported $193.7M worth of top line sales in its most recent quarter.
Argan announced earnings per share of $1.60 which represents a beat of analyst forecast a $1.09 per share.
Argan reported $36.9M that represents $2.61 per share over the last quarter.
Argan's earnings are forecast to grow from $6.15 per share to $5.06 per share next year representing an increase of 6.67%.
Argan's next earnings date is September 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.